Why the study?
Does indomethacin attenuate the hypotensive effect of captopril in DOCA/salt hypertensive rats?
Does indomethacin attenuate the hypotensive effect of captopril in DOCA/salt hypertensive rats?
The hypotensive effect of captopril in DOCA/salt hypertensive rats is attenuated by indomethacin, suggesting the blood pressure lowering effect may be partially mediated by prostaglandins.
Answers are grounded in this paper and cite their sources.
Indomethacin attenuates captopril hypotension in this rat model; leaves open prostaglandin mediation of ACE inhibitors in clinical hypertension.
The effect of an oral angiotensin I converting enzyme inhibitor, SQ 14225 (Captopril) on blood pressure and plasma renin activity (PRA) was studied in deoxycorticosterone-salt (DOCA/salt) hypertensive rats. Intraperitoneal (ip) injection of captopril (1 mg/kg) produced a significant fall in systolic blood pressure (23.4 +/- 5.0 mm Hg, p < 0.001) whereas no significant change in blood pressure occurred in control rats. Indomethacin (IDM) (2.5 mg/kg ip) pretreatment significantly (p < 0.01) attenuated the hypotensive action of captopril in DOCA/salt rats. PRA was markedly suppressed in DOCA/salt rats (0.3 +/- 0.1 ng/ml/hr) when compared with the normotensive controls (4.4 +/- 2.2 ng/ml/hr, p < 0.001) at baseline. Captopril induced a significant rise in PRA in both groups of rats. These responses were not significantly altered by IDM pretreatment. The hypotensive effect of captopril in the DOCA/salt model may be mediated by prostaglandins since their synthesis is inhibited by indomethacin.
No takes yet. Share an insight, caveat, or question.
Miyamori et al. (1980) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: